Back
Eli Lilly and Vs. Viking Therapeutics Industry Stock Comparison
Sell
42
LLY
Eli Lilly and
Last Price:
$776.49
Seasonality Move:
2.84%
Sell
24
VKTX
Viking Therapeutics
Last Price:
$39.81
Seasonality Move:
21.99%
Sell
42
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
-
The current Eli Lilly and [LLY] share price is $783.17. The Score for LLY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
-
The current Viking Therapeutics [VKTX] share price is $41.16. The Score for VKTX is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $783.17Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $41.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.45 | Sell |
Relative Strength Index (14 RSI): | 46.26 | Sell |
Chaikin Money Flow: | -916127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (766.13 - 810.57) | Sell |
Bollinger Bands (100): | (794.84 - 929.44) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.9 | Sell |
Relative Strength Index (14 RSI): | 32.74 | Sell |
Chaikin Money Flow: | -1637199 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.41 - 52.39) | Sell |
Bollinger Bands (100): | (50.34 - 67.38) | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 779.74 | Buy |
20-day SMA: | 793.91 | Sell |
50-day SMA: | 811.27 | Sell |
200-day SMA: | 838.45 | Sell |
8-day EMA: | 785.46 | Sell |
20-day EMA: | 788.72 | Sell |
50-day EMA: | 810.9 | Sell |
200-day EMA: | 807.06 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.15 | Sell |
20-day SMA: | 46.67 | Sell |
50-day SMA: | 55.94 | Sell |
200-day SMA: | 61.22 | Sell |
8-day EMA: | 42.89 | Sell |
20-day EMA: | 46.32 | Sell |
50-day EMA: | 52.42 | Sell |
200-day EMA: | 53.88 | Sell |
Eli Lilly and Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.86 per share, and an increase next year of $9.50 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
Eli Lilly and Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |